Clinical Trial

App-Based Certified Diabetes Education Therapy (AB-CDE)

Study acronym: AB-CDE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn more about a smartphone application (app) called DailyDose, an investigational decision support tool that may help in managing your diabetes. DailyDose tracks your continuous glucose monitoring (CGM) data, insulin use, and exercise, and uses this information to provide personalized recommendations for insulin dosing and carbohydrate intake during exercise or low blood sugar events. We want to find out if DailyDose can help lower blood sugar levels as measured by the hemoglobin A1c (HbA1c) test.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-05.
Trial Details
NCT Number NCT07282639
Lead Sponsor Oregon Health and Science University
Collaborators: Leona M. & Harry B. Helmsley Charitable Trust
Conditions Type 1 Diabetes (T1D)
Enrollment 99 participants
Start Date 2026-01-15
Primary Completion 2027-05-15 (estimated)
Study Completion 2027-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-26